Brief: Marinus Pharmaceuticals Announces Collaboration With Tenacia Biotechnology For Ganaxolone Development And Commercialization In China

Marinus Pharmaceuticals

17/11/2022 12:43

Nov 17 (Reuters) - Marinus Pharmaceuticals Inc  MRNS.O :
    * MARINUS PHARMACEUTICALS ANNOUNCES COLLABORATION WITH
TENACIA
BIOTECHNOLOGY FOR GANAXOLONE DEVELOPMENT AND COMMERCIALIZATION
IN CHINA
    * MARINUS - TO RECEIVE UPFRONT FEE OF $10 MILLION AND
ELIGIBLE TO
RECEIVE UP TO $256 MILLION IN DEVELOPMENT, REGULATORY AND
COMMERCIALIZATION MILESTONE PAYMENTS
    * MARINUS PHARMACEUTICALS INC - TO RECEIVE TIERED LOW
DOUBLE-DIGIT
ROYALTIES ON NET SALES IN CHINA
    * MARINUS - TENACIA TO GET EXCLUSIVE RIGHTS TO DEVELOP &
COMMERCIALIZE SOME FORMULATIONS OF GANAXOLONE IN MAINLAND CHINA,
HONG KONG, MACAU & TAIWAN

Source text for Eikon:  ID:nBw8GFDJ8a 
Further company coverage:  MRNS.O 
 ((Reuters.Briefs@thomsonreuters.com;))